Bookmark this page for future reference
Please email your AbbVie medical representative if you require any further information:
In-Field Medical Advisor Migraine
ABBV-IE-XXXXX-XX. Date of Preparation: November 2025.
Reporting an Adverse Event: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Health Products Regulatory Authority (HPRA) Pharmacovigilance. www.hpra.ie.
This website is intended for Healthcare Professionals working in Ireland
Copyright© 2025 AbbVie Inc. All rights reserved.
AbbVie Pro Medical is developed and funded by AbbVie Limited
AbbVie Limited, a private company limited by Shares, and a member of the AbbVie group of companies.
Registered in Ireland with Company Number 510846.
Local contact details: 14 Riverwalk, Citywest Business Campus, Dublin 24, D24 XN32, Ireland. Tel (0) 1 4287900. www.abbvie.ie